The brachytherapy market has seen considerable growth due to a variety of factors.
• The brachytherapy market has experienced strong growth in recent years. It will grow from $0.93 billion in 2024 to $1.01 billion in 2025 at a CAGR of 8.1%.
This growth is due to the increasing incidence of cancer, heightened awareness and early detection efforts, growing recognition of brachytherapy’s effectiveness and reduced side effects, and favorable reimbursement policies.
The brachytherapy market is expected to maintain its strong growth trajectory in upcoming years.
• The brachytherapy market is expected to see strong growth, reaching $1.37 billion by 2029 at a CAGR of 7.9%.
Growth drivers include personalized treatments, higher cancer rates in the elderly, expanded healthcare facilities, increased cancer treatment investments, and a preference for less invasive options. Trends include brachytherapy innovation, personalized medicine, advanced imaging for real-time guidance, outpatient procedures, and advanced technology integration.
The growing cancer burden is expected to drive the growth of the brachytherapy market. The rise in cancer cases, driven by aging populations, lifestyle changes, and environmental factors, is increasing the demand for targeted treatments like brachytherapy. According to the American Cancer Society in January 2022, 1.9 million new cancer cases and 609,360 cancer-related deaths were projected in the US in 2022. Brachytherapy offers a localized treatment option that reduces side effects and treatment duration.
The brachytherapy market covered in this report is segmented –
1) By Product Type: Seeds, Applicators And Afterloaders, Electronic Brachytherapy
2) By Dosage Type: High-Dose Rate (HDR) Brachytherapy, Low-Dose Rate (LDR) Brachytherapy
3) By Application: Prostate Cancer, Gynecological Cancer, Breast Cancer, Other Applications
4) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Seeds: Iodine-125 Seeds, Palladium-103 Seeds, Cesium-131 Seeds, Other Radioactive Seeds
2) By Applicators And Afterloaders: Prostate Applicators, Vaginal Applicators, Interstitial Applicators, Skin Applicators, Afterloaders
3) By Electronic Brachytherapy: Electronic Brachytherapy Units, Electronic Brachytherapy Sources
Companies in the brachytherapy market are developing advanced technological solutions such as standard afterloader technology to improve treatment precision. Standard afterloader devices are used to deliver radioactive sources to tumors in a precise manner. In April 2024, Varian Medical Systems, a US-based company, partnered with Maastro to launch a 3D-printed brachytherapy applicator for rectal cancer that ensures accurate radiation dose delivery.
Major companies operating in the brachytherapy market are:
• Siemens Healthineers
• Becton Dickinson and Company
• Boston Scientific Corporation
• Hologic Inc.
• Varian Medical Systems Inc.
• Carl Zeiss AG
• Elekta
• Argon Medical Devices Inc.
• Sirtex Medical Limited
• Theragenics Corporation
• RaySearch Laboratories
• Nanobiotix SA
• CIVCO Medical Solutions
• Eckert Ziegler Bebig GmbH
• iCAD Inc.
• IsoAid
• C4 Imaging LLC
• Mick Radio-Nuclear Instruments Inc.
• Huiheng Medical Inc.
• Best Medical International Inc.
• Cianna Medical Inc.
North America was the largest region in the brachytherapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brachytherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.